Man Group plc: BRSL position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Man Group plc on BRSL, newest first. How the timeline and the estimate are built.
Man Group plc held 0 BRSL shares at 2025-12-31 per its 13F-HR filed 2026-02-17.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -16,735 shares
13F-HR 0001637460-26-000001 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 16,735 sharesChange vs previous 13F -37,037 shares
<0.01% of the 13F portfolio, value $288,679.
13F-HR 0001637460-25-000003 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 53,772 sharesChange vs previous 13F -636,104 shares
<0.01% of the 13F portfolio, value $850,135.
13F-HR 0001085146-25-005287 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 689,876 sharesChange vs previous 13F +213,650 shares
0.03% of the 13F portfolio, value $11,217,384.
13F-HR 0001085146-25-003321 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 476,226 sharesChange vs previous 13F -48,008 shares
0.03% of the 13F portfolio, value $8,410,151.
13F-HR 0001085146-25-001694 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 524,234 sharesChange vs previous 13F not available
0.03% of the 13F portfolio, value $11,166,184.
13F-HR 0001085146-24-005932 filed by Man Group plc
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).